Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM

Diabetologia

Volumn 39, Issue 1, 1996, Pages 97-102

  Doi, Y ^a   Yoshizumi, H ^a   Yoshinari, M ^a   Iino, K ^a   Yamamoto, M ^a   Ichikawa, K ^a   Iwase, M ^a   Fujishima, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme; Diabetes mellitus; Nephropathy; Polymorphism; Retinopathy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINOPATHY;

ALLELES; BASE SEQUENCE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEINURIA; REFERENCE VALUES; RENAL DIALYSIS;

EID: 0030044581     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Klein R, Klein BE, Moss S, DeMets DL (1988) Proteinuria in diabetes. Arch Intern Med 148: 181-186
2. Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590-596
3. Rettig P, Teutseh S (1984) The incidence of end-stage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy 3: 26-27
4. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE (1992) Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 41: 731-735
5. Klein R, Klein BE, Moss SE (1984) The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526
6. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532
7. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165
8. Borch-Johonsen K, Norgaard K, Hommel E et al. (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41: 719-722
9. Parving HH, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 297: 1086-1091
10. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med 329: 1456-1462
11. Zatz R, Meyer TW, Rennke HG, Brenner BM (1985) Predominance of haemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963-5967
12. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930
13. Anderson S, Rennke HG, Garcia DL, Brenner BM (1989) Short and long term effects of anti-hypertensive therapy in the diabetic rat. Kidney Int 36: 526-536
14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
15. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F (1993) Angiotensin 1-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290: 33-40
16. Tiret L, Rigat B, Visvikis S et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197-205
17. Marre M, Bernadet P, Gallois Y et al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388
18. Schmidt S, Schone N, Ritz L, and the Diabetic Nephropathy Study Group (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47: 1176-1181
19. Tarnow L, Cambien F, Rossing P et al. (1994) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44(5):489-494
20. Fujisawa T, Ikegami H, GQ Shen et al. (1995) Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18: 983-985
21. Group WS (1985) Report on diabetes mellitus. World Health Organization, Technical Report Series 727, Geneva
22. Gatling W, Knight C, Mullee MA, Hill RD (1988) Microalbuminuria in diabetes; a population study of the prevalence and an assessment of three screening tests. Diabet Med 5: 343-347
23. Cohen DL, Close CF, Viberti GC (1987) The variability of overnight urinary albumin excretion on insulin-dependent diabetic and normal subjects. Diabet Med 4: 437-440
24. Tuji K, Aizawa M, Sasazuki T (1992) Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. vol 1. Oxford University Press, Oxford, pp 397-419
25. Lindpaintner K, Pfeffer MA, Kreutz R et al. (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332: 706-711
26. Lee EJ (1994) Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 37: 212-214
27. Nomura H, Koni I, Michishita Y, Morise T, Takeda R (1994) Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Lancet 343: 482-483
28. Mogensen C (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360
29. Jarrett R, Viberti C, Argyropoulos A (1984) Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabet Med 1: 17-19
30. Schmiz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5: 126-134
31. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41: 736-741
32. Cambien F, Poirier O, Lecerf L et al. (1993) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644
33. Tiret L, Kee F, Poirier O et al. (1943) Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341: 991-992
34. Zhao Y, Higashimori K, Higaki J et al. (1994) Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 17: 55-57
35. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 8287: 1430-1432
36. Mangili R, Bending JJ, Scott G, Li-LK, Gupta A, Viverti G (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 146-150
37. Herman WH, Prior DE, Yassine MD, Weder AB (1993) Nephropathy in NIDDM is associated with cellular markers for hypertension. Diabetes Care 16: 815-818
38. Cordonnier DJ, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J (1993) Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories. Diabetologia 36: 1109-1112
39. Kikkawa R, Arimura T, Haneda M et al. (1993) Current status of type 2 (non-insulin-dependent) diabetic subjects on dialysis therapy in Japan. Diabetologia 36: 1105-1108
40. Marian AJ, Yu QT, Workman R, Greve G, Roberts R (1993) Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085-1086
41. Ballard DJ, Humphrey LL, Melton LJ III et al. (1988) Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37: 405-412
42. Sasaki A, Horinouchi N, Hasegawa K, Uehara M (1986) Risk factors related to the development of persistent albuminuria among diabetic patients observed in a long-term follow-up. J of the Jpn Diabetes Soc 29: 1017-1023
43. Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH (1989) Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 35: 681-687
44. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496-501
45. Parving HH, Larsen M, Hommel E, Lund-Andersen H (1989) Effect of anti-hypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32: 440-444
46. Ferrari-Dileo G, Davis EB, Anderson DR (1987) Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci 28: 1747-1751
47. Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105: 141-145